CDK-inhibitors-associated kinase activity: A possible determinant of malignant potential in smooth muscle tumors of the external soft tissue

Yoh Dobashi, Takashi Noguchi, Shuji Nasuno, Kazuhiro Katayama, Toru Kameya

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

There has been accumulating histological observation of leiomyoma and leiomyosarcoma of the external soft tissue regarding their differential diagnosis. The definitive diagnostic tools have not been established, however, nor have the pathological mechanisms of cell proliferation in these tumors been clarified. Herein, expression of the cyclin-dependent kinase inhibitors (CKIs), p21, p27 and p57 and their associated kinase activities were examined in 61 cases of soft tissue smooth muscle tumors. Immunohistochemical staining showed that all 3 inhibitor proteins were expressed in all cases of leiomyoma and leiomyosarcoma, but that the mean values of their labeling indices (LIs) were higher in the cases of leiomyosarcoma. In addition, the Lis of p21 and p27 were inversely correlated in total cases. Immunoblotting revealed that these proteins are expressed at higher levels in tumors, in particular, in leiomyosarcoma. When CKIs were immuno-precipitated from tissue extracts, cyclin/cdk protein complexes associated with, at least, I CKI were detectable only in tumor tissues. Furthermore, cdk2 or cdk4 kinase activity manifested by these cyclin/cdk/CKI complexes (CKI-associated kinase activity) was detectable exclusively from leiomyosarcoma, but not from leiomyoma. Among the cases of leiomyosarcoma, cdk2 activity was generally found associated either with p21 or p27, but not both. Statistical analysis indicated that p21- and p27 LIs are predictive of positive or negative clinical outcome, respectively. In conclusion, the participation of CKIs in active cyclin/cdk complexes in a reciprocal and redundant manner and subsequent CKI-associated kinase activity are the characteristic profiles of malignant phenotype in these tumors. Moreover, immuno-histochemical detection of CKIs may provide a useful tool for evaluating patients' prognosis.

Original languageEnglish
Pages (from-to)353-362
Number of pages10
JournalInternational Journal of Cancer
Volume94
Issue number3
DOIs
Publication statusPublished - 2001 Nov 1
Externally publishedYes

Fingerprint

Smooth Muscle Tumor
Cyclin-Dependent Kinases
Leiomyosarcoma
Phosphotransferases
Cyclins
Leiomyoma
Cyclin-Dependent Kinase Inhibitor p57
Neoplasms
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Tissue Extracts
Immunoblotting
Proteins
Differential Diagnosis
Cell Proliferation
Observation
Staining and Labeling
Phenotype

Keywords

  • Cdk-inhibitors
  • Cell cycle
  • External soft tissue
  • Kinase activity
  • Smooth muscle tumors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

CDK-inhibitors-associated kinase activity : A possible determinant of malignant potential in smooth muscle tumors of the external soft tissue. / Dobashi, Yoh; Noguchi, Takashi; Nasuno, Shuji; Katayama, Kazuhiro; Kameya, Toru.

In: International Journal of Cancer, Vol. 94, No. 3, 01.11.2001, p. 353-362.

Research output: Contribution to journalArticle

Dobashi, Yoh ; Noguchi, Takashi ; Nasuno, Shuji ; Katayama, Kazuhiro ; Kameya, Toru. / CDK-inhibitors-associated kinase activity : A possible determinant of malignant potential in smooth muscle tumors of the external soft tissue. In: International Journal of Cancer. 2001 ; Vol. 94, No. 3. pp. 353-362.
@article{4c79e302890e47ec9823624649169f7b,
title = "CDK-inhibitors-associated kinase activity: A possible determinant of malignant potential in smooth muscle tumors of the external soft tissue",
abstract = "There has been accumulating histological observation of leiomyoma and leiomyosarcoma of the external soft tissue regarding their differential diagnosis. The definitive diagnostic tools have not been established, however, nor have the pathological mechanisms of cell proliferation in these tumors been clarified. Herein, expression of the cyclin-dependent kinase inhibitors (CKIs), p21, p27 and p57 and their associated kinase activities were examined in 61 cases of soft tissue smooth muscle tumors. Immunohistochemical staining showed that all 3 inhibitor proteins were expressed in all cases of leiomyoma and leiomyosarcoma, but that the mean values of their labeling indices (LIs) were higher in the cases of leiomyosarcoma. In addition, the Lis of p21 and p27 were inversely correlated in total cases. Immunoblotting revealed that these proteins are expressed at higher levels in tumors, in particular, in leiomyosarcoma. When CKIs were immuno-precipitated from tissue extracts, cyclin/cdk protein complexes associated with, at least, I CKI were detectable only in tumor tissues. Furthermore, cdk2 or cdk4 kinase activity manifested by these cyclin/cdk/CKI complexes (CKI-associated kinase activity) was detectable exclusively from leiomyosarcoma, but not from leiomyoma. Among the cases of leiomyosarcoma, cdk2 activity was generally found associated either with p21 or p27, but not both. Statistical analysis indicated that p21- and p27 LIs are predictive of positive or negative clinical outcome, respectively. In conclusion, the participation of CKIs in active cyclin/cdk complexes in a reciprocal and redundant manner and subsequent CKI-associated kinase activity are the characteristic profiles of malignant phenotype in these tumors. Moreover, immuno-histochemical detection of CKIs may provide a useful tool for evaluating patients' prognosis.",
keywords = "Cdk-inhibitors, Cell cycle, External soft tissue, Kinase activity, Smooth muscle tumors",
author = "Yoh Dobashi and Takashi Noguchi and Shuji Nasuno and Kazuhiro Katayama and Toru Kameya",
year = "2001",
month = "11",
day = "1",
doi = "10.1002/ijc.1479",
language = "English",
volume = "94",
pages = "353--362",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - CDK-inhibitors-associated kinase activity

T2 - A possible determinant of malignant potential in smooth muscle tumors of the external soft tissue

AU - Dobashi, Yoh

AU - Noguchi, Takashi

AU - Nasuno, Shuji

AU - Katayama, Kazuhiro

AU - Kameya, Toru

PY - 2001/11/1

Y1 - 2001/11/1

N2 - There has been accumulating histological observation of leiomyoma and leiomyosarcoma of the external soft tissue regarding their differential diagnosis. The definitive diagnostic tools have not been established, however, nor have the pathological mechanisms of cell proliferation in these tumors been clarified. Herein, expression of the cyclin-dependent kinase inhibitors (CKIs), p21, p27 and p57 and their associated kinase activities were examined in 61 cases of soft tissue smooth muscle tumors. Immunohistochemical staining showed that all 3 inhibitor proteins were expressed in all cases of leiomyoma and leiomyosarcoma, but that the mean values of their labeling indices (LIs) were higher in the cases of leiomyosarcoma. In addition, the Lis of p21 and p27 were inversely correlated in total cases. Immunoblotting revealed that these proteins are expressed at higher levels in tumors, in particular, in leiomyosarcoma. When CKIs were immuno-precipitated from tissue extracts, cyclin/cdk protein complexes associated with, at least, I CKI were detectable only in tumor tissues. Furthermore, cdk2 or cdk4 kinase activity manifested by these cyclin/cdk/CKI complexes (CKI-associated kinase activity) was detectable exclusively from leiomyosarcoma, but not from leiomyoma. Among the cases of leiomyosarcoma, cdk2 activity was generally found associated either with p21 or p27, but not both. Statistical analysis indicated that p21- and p27 LIs are predictive of positive or negative clinical outcome, respectively. In conclusion, the participation of CKIs in active cyclin/cdk complexes in a reciprocal and redundant manner and subsequent CKI-associated kinase activity are the characteristic profiles of malignant phenotype in these tumors. Moreover, immuno-histochemical detection of CKIs may provide a useful tool for evaluating patients' prognosis.

AB - There has been accumulating histological observation of leiomyoma and leiomyosarcoma of the external soft tissue regarding their differential diagnosis. The definitive diagnostic tools have not been established, however, nor have the pathological mechanisms of cell proliferation in these tumors been clarified. Herein, expression of the cyclin-dependent kinase inhibitors (CKIs), p21, p27 and p57 and their associated kinase activities were examined in 61 cases of soft tissue smooth muscle tumors. Immunohistochemical staining showed that all 3 inhibitor proteins were expressed in all cases of leiomyoma and leiomyosarcoma, but that the mean values of their labeling indices (LIs) were higher in the cases of leiomyosarcoma. In addition, the Lis of p21 and p27 were inversely correlated in total cases. Immunoblotting revealed that these proteins are expressed at higher levels in tumors, in particular, in leiomyosarcoma. When CKIs were immuno-precipitated from tissue extracts, cyclin/cdk protein complexes associated with, at least, I CKI were detectable only in tumor tissues. Furthermore, cdk2 or cdk4 kinase activity manifested by these cyclin/cdk/CKI complexes (CKI-associated kinase activity) was detectable exclusively from leiomyosarcoma, but not from leiomyoma. Among the cases of leiomyosarcoma, cdk2 activity was generally found associated either with p21 or p27, but not both. Statistical analysis indicated that p21- and p27 LIs are predictive of positive or negative clinical outcome, respectively. In conclusion, the participation of CKIs in active cyclin/cdk complexes in a reciprocal and redundant manner and subsequent CKI-associated kinase activity are the characteristic profiles of malignant phenotype in these tumors. Moreover, immuno-histochemical detection of CKIs may provide a useful tool for evaluating patients' prognosis.

KW - Cdk-inhibitors

KW - Cell cycle

KW - External soft tissue

KW - Kinase activity

KW - Smooth muscle tumors

UR - http://www.scopus.com/inward/record.url?scp=0035501655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035501655&partnerID=8YFLogxK

U2 - 10.1002/ijc.1479

DO - 10.1002/ijc.1479

M3 - Article

C2 - 11745414

AN - SCOPUS:0035501655

VL - 94

SP - 353

EP - 362

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -